HELIPAQ CERECYTE CHE180730-30Recalls & reported problems
Medos International Sàrl · HELIPAQ microcoil HELIPAQ 18 CERECYTE Coil 7mm x 30cm 190cm Contents: 1 Detachable Coil System · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00878528000778), received between Dec 16, 2016 and Oct 9, 2017 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Positioning Failure” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Positioning Failure1
- Premature Activation1
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 9, 2017Positioning Failure; Positioning Failure
IT WAS REPORTED BY A HEALTHCARE PROFESSIONAL THAT A HELI 18 CERE COIL (CHE18073030/C40080) WOULD NOT DETACH DURING A COILING PROCEDURE. THEY TRIED EVERYTHING. THE DEVICE IS BEING RETURNED FOR EVALUATION.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6930389 ↗MalfunctionDec 16, 2016Premature Activation; Premature Activation
IT WAS REPORTED BY A HEALTH CARE PROFESSIONAL THAT DURING AN INTERVENTION THE SURGEON RECOGNIZED THE WHITE SHEATH OF A HELIPAQ CERE 7MM X 30 CM COIL (CHE18073030/C14002)TO BE DEFECTIVE, IT WAS TORN. THE COIL INTRODUCER SHEATH WAS FOUND TO BE SPLIT OPEN. THE PRODUCT ISSUE WAS DISCOVERED BEFORE IT WAS USED ON THE PATIENT. THE PROCEDURE WAS COMPLETED WITH A SAME LIKE PRODUCT. NO SIGNIFICANT DELAY OR PATIENT HARM REPORTED. THERE WERE NO INTRA OR POST PROCEDURAL COMPLICATIONS RELATED TO DEVICE OR REPORTED EVENT. THERE WERE NO OTHER ISSUES REPORTED WITH THE PRODUCT. IT WAS INITIALLY REPORTED THAT THE COMPLAINT DEVICE IS AVAILABLE FOR RETURN.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6181283 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page